Assessment of the Feasibility of a Systematic Multidimensional Evaluation of the Outcome of Traumatic Brain Injury Patients and Their Relatives.

NCT ID: NCT06194071

Last Updated: 2024-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-11

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective is to assess the feasibility of collecting and implementing a multidimensional evaluation in a sample of patients with a mild to severe traumatic brain injury (TBI) and their relatives, evaluated at 6 months (primary outcome), and at 12 then 18 months post-injury (secondary outcomes).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study aims to assess the feasibility of collecting multidimensional outcomes of patients with traumatic brain injury, taking into account the patient-relative dyad. However, this multidimensional assessment may pose enormous problems of feasibility during the follow-up: loss of the patient's pathway, moderate acceptance by patients and relatives, difficulties of remote assessment sometimes carried out several times.... All these factors can affect the methodological quality of the evaluation of patient outcomes, with measurement and reporting biases influencing the results of biomedical trials. In order to improve the quality of clinical research in this field, it is therefore essential to fully appreciate the factors that facilitate or, on the contrary, hinder high-quality longitudinal follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Brain Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with Traumatic Brain Injury

Patients with all types of TBI will be recruited (mild, moderate and severe). They mus accept participation in the prolonged follow-up (up to 18 months after the accident). Relatives will also accept to participate. Patients will undergo routine care regarding TBI in our institution. Only the prolonged follow-up and monitoring is proposed which combines remote questionnaire completion, and on-site visits at 3 time-points (6, 12 and 18 months). No on-site visit is proposed for relatives who will fill out questionnaires. However, they may accompany patients during on-sites visits.

Completion of questionnaires and on-site visits during an 18 months follow-up after TBI

Intervention Type OTHER

We will evaluate the same outcomes and use the same questionnaires at 6, 12 and 18 months post-TBI.

For patients we will evaluate:

* Functional Outcome (GOS-Extended)
* Health-related Quality of Life (QOLIBRI)
* Neurocognitive tests (MoCA)
* Independence (Barthel Index)
* Daily issues (BICOQ)
* Anxiety and depression symptoms (HADS)
* Medico-economic evaluation (EQ5D-5L)

For Relatives we will evaluate:

* Symptoms of anxiety and depression (HADS)
* The appreciation of the patient's daily issues from their point of view (dedicated Bicoq for relatives)
* Burden of care (ZARIT)

Throughout the follow-up we will nest a qualitative research programs which will focus on several aspects:

* feasibility of such follow-up (6 months is the primary endpoint) defined as the drop-out rate, complete or incomplete completion of scales and their reasons
* factors that may lead to drop-out or the contrary that solidifies the follow-up

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Completion of questionnaires and on-site visits during an 18 months follow-up after TBI

We will evaluate the same outcomes and use the same questionnaires at 6, 12 and 18 months post-TBI.

For patients we will evaluate:

* Functional Outcome (GOS-Extended)
* Health-related Quality of Life (QOLIBRI)
* Neurocognitive tests (MoCA)
* Independence (Barthel Index)
* Daily issues (BICOQ)
* Anxiety and depression symptoms (HADS)
* Medico-economic evaluation (EQ5D-5L)

For Relatives we will evaluate:

* Symptoms of anxiety and depression (HADS)
* The appreciation of the patient's daily issues from their point of view (dedicated Bicoq for relatives)
* Burden of care (ZARIT)

Throughout the follow-up we will nest a qualitative research programs which will focus on several aspects:

* feasibility of such follow-up (6 months is the primary endpoint) defined as the drop-out rate, complete or incomplete completion of scales and their reasons
* factors that may lead to drop-out or the contrary that solidifies the follow-up

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients admitted to ICU with Glasgow score during initial car ≤ 14 and CT-confirmed head injury
* Patients admitted to ER with Glasgow score during initial care ≤ 15 or concussion and CT-confirmed head injury or displaying clinicalsigns such as headaches or vomiting.

Exclusion Criteria

* Patients under 18 years of age
* Single patient, without relative or informal caregiver
* Non-French-speaking patient
* Refusal of consent
* Patient under guardianship
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nantes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Nantes

Nantes, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Raphaël CINOTTI, Pr

Role: CONTACT

+33(0)240084731

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Raphaël Cinotti, Pr

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AR_2023_002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mild TBI Assessment & Rehabilitation
NCT02920788 ACTIVE_NOT_RECRUITING NA
Intervention to Change Affect Recognition and Empathy
NCT05636020 ACTIVE_NOT_RECRUITING NA